Dan Groman Biography and Net Worth

Chief Technology Officer of Enfusion

Dan Groman is Chief Technology Officer at Enfusion where he leads Enfusion’s Engineering Infrastructure and Security teams. Groman joined Enfusion in 2016 and has led the expansion of Enfusion’s SaaS native platform, which has enabled growth into new client segments. He was appointed to his current role in July 2021.

Prior to joining Enfusion, Groman served as an engineer at CME Group. He began his career working with insurance companies, asset managers and hedge funds in product and middle/back-office operating roles.

Groman holds a bachelor’s degree in Economics from the University of Maryland and a master’s degree in Computer Science from DePaul University.

What is Dan Groman's net worth?: The estimated net worth of Dan Groman is at least $1.49 million as of November 14th, 2023. Mr. Groman owns 133,828 shares of Enfusion stock worth more than $1,493,520 as of April 2nd. This net worth estimate does not reflect any other assets that Mr. Groman may own. Learn More about Dan Groman's net worth.
How old is Dan Groman?: Mr. Groman is currently 35 years old. There are 6 older executives and no younger executives at Enfusion. The oldest executive at Enfusion is Mr. Bradley Herring, Chief Financial Officer, who is 53 years old. Learn More on Dan Groman's age.
How do I contact Dan Groman?: The corporate mailing address for Mr. Groman and other Enfusion executives is , , . Enfusion can also be reached via phone at 312-253-9800 and via email at brian.murphy@icrinc.com. Learn More on Dan Groman's contact information.
Has Dan Groman been buying or selling shares of Enfusion?: Dan Groman has not been actively trading shares of Enfusion within the last three months. Most recently, Dan Groman sold 5,000 shares of the business's stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $9.97, for a transaction totalling $49,850.00. Following the completion of the sale, the chief technology officer now directly owns 133,828 shares of the company's stock, valued at $1,334,265.16. Learn More on Dan Groman's trading history.
Who are Enfusion's active insiders?: Enfusion's insider roster includes Bronwen Bastone (Chief People Officer), Matthew Campobasso (General Counsel), Dan Groman (Chief Technology Officer), Bradley Herring (CFO), Roy Luo (Director), Oleg Movchan (CEO), Neal Pawar (Chief Operating Officer), and Deirdre Somers (Director). Learn More on Enfusion's active insiders.
Are insiders buying or selling shares of Enfusion?: During the last twelve months, insiders at the sold shares 29 times. They sold a total of 160,582 shares worth more than $1,648,833.48. The most recent insider tranaction occured on March, 6th when CEO Oleg Movchan sold 11,452 shares worth more than $130,438.28. Insiders at Enfusion own 36.4% of the company. Learn More about insider trades at Enfusion.
Information on this page was last updated on 3/6/2025.

Dan Groman Insider Trading History at Enfusion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/14/2023	Sell	5,000	$9.97	$49,850.00	133,828
10/17/2023	Sell	5,000	$9.09	$45,450.00	138,828
9/19/2023	Sell	5,000	$9.07	$45,350.00	143,828
8/14/2023	Sell	1,760	$7.89	$13,886.40	119,418
8/11/2023	Sell	1,850	$8.10	$14,985.00	117,133
8/9/2023	Sell	2,317	$8.32	$19,277.44	111,783
7/17/2023	Sell	3,877	$11.31	$43,848.87	108,841
6/20/2023	Sell	3,877	$8.86	$34,350.22	112,718
5/10/2023	Sell	15,048	$8.34	$125,500.32	79,809
4/17/2023	Sell	3,877	$9.66	$37,451.82	82,102
3/17/2023	Sell	3,877	$10.94	$42,414.38	85,979
1/17/2023	Sell	3,877	$10.93	$42,375.61	80,976

Dan Groman Buying and Selling Activity at Enfusion

Enfusion Company Overview

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Today's Range

Now: $11.16

$11.07

$11.17

50 Day Range

MA: $11.18

$11.01

$11.50

2 Week Range

Now: $11.16

$7.83

$11.80

Volume

496,438 shs

Average Volume

555,547 shs

Market Capitalization

$1.44 billion

P/E Ratio

279.07

Dividend Yield

N/A

Beta

0.95

Dan Groman Biography and Net Worth

What is Dan Groman's net worth?

How old is Dan Groman?

How do I contact Dan Groman?

Has Dan Groman been buying or selling shares of Enfusion?

Who are Enfusion's active insiders?

Are insiders buying or selling shares of Enfusion?